Cardiovascular Treatment

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00839579
First received: February 6, 2009
Last updated: March 6, 2014
Last verified: March 2014
  Purpose

Exercise training is proved to protect against premature cardiovascular mortality. Additionally there is evidence that relatively high exercise intensity may be an important factor for improving aerobic capacity and endothelial function in patients with post-infarction heart failure, metabolic syndrome, coronary artery disease, as well as in overweight and obese individuals.

The aim of this study is to investigate the amount of high-intensity exercise needed to improve aerobic capacity and endothelial function.


Condition Intervention
Obesity
Other: 1x4 min interval

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: How Little Pain for Cardiac Gain? A Pilot Study

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • Maximal oxygen consumption and endothelial function [ Time Frame: baseline and 12 weeks followup ] [ Designated as safety issue: No ]

Enrollment: 26
Study Start Date: January 2009
Study Completion Date: June 2010
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 4x4min
4x4minutes interval group
Other: 1x4 min interval
Aerobic interval training
Experimental: 1x4min Other: 1x4 min interval
Aerobic interval training

  Eligibility

Ages Eligible for Study:   35 Years to 45 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • BMI: 25-30
  • Males, 35-45 years
  • Healthy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00839579

Locations
Norway
Norwegian University of Science and Technology
Trondheim, Norway, 7489
Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Study Chair: Arnt E Tjønna, PhD Norwegian University of Science and Technology
Principal Investigator: Ulrik Wisløff, PhD Norwegian University of Science and Technology
  More Information

Publications:
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00839579     History of Changes
Other Study ID Numbers: 1x4min interval
Study First Received: February 6, 2009
Last Updated: March 6, 2014
Health Authority: Norway:National Committee for Medical and Health Research Ethics

Keywords provided by Norwegian University of Science and Technology:
slightly overweight
males 35-45 years

ClinicalTrials.gov processed this record on September 16, 2014